AHA 2018 | Endocarditis Prophylaxis More Limited after AHA 2007 Guidelines

The incidence of infective endocarditis had decreased after AHA 2007 recommendations. At present, some patients are not receiving antibiotic prophylaxis as they should.

Disminuye la profilaxis de endocarditis luego de las guías del 2007After AHA restricted the use of antibiotic prophylaxis in 2007, high-risk patients undergoing dental procedures were prescribed less antibiotics. These patients had always been prescribed antibiotic prophylaxis, regardless they had less restrictive guidelines.  

 

At the same time, we observe a surprising trend towards lower incidence of infections endocarditis, which calls our attention. All these cases were presented at AHA annual meeting in 2018, and simultaneously published in JACC.


Read also: AHA 2018 | Freedom Long-Term Follow-up: Still in Favor of CABG.


In moderate risk patients, there was a more appropriate reduction of antibiotic prophylaxis after the new recommendations, with a more modest reduction in endocarditis rate for this group.

 

Even though this is an observational study, and we are no table to establish a cause-effect relationship between prescription frequency and endocarditis incidence, these finding support guideline recommendations.

 

However, we should not drop our guard: all high-risk patients undergoing dental procedures should receive antibiotic prophylaxis (not those at moderate risk).

 

Researchers estimate antibiotic prophylaxis has fallen across all groups since 2007 AHA recommendations. The drop has affected 52% of low or unknown risk patients, 64% of patients at moderate risk and 20% of high-risk patients.

 

Original title: Antibiotic prophylaxis and incidence of endocarditis before and after the 2007 AHA recommendations.

Reference: Thornhill et al. J Am Coll Cardiol. 2018;72:2543-2554.

 

profilaxis-antibiótica


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...